S0931:A Phase III Trial of Everolimus for Renal Cell Ensuing Surgical Therapy

This study is for renal cancer patients who have undergone full surgical resection (radical nephrectomy or partial nephrectomy). Patients must be considered pathologically either intermediate hight risk or very high risk for recurrence.

Primary Sponsor:
Southwest Oncology Group (SWOG)

Prinicipal Investigator:
Jeanny Aragon-Ching, M.D.

Contact Phone:
202-741-2981

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
     
Verification Code *

Please type what you see (all uppercase):